Gaucher's disease
Sign in to saveAlso known as Gaucher disease, acid beta-glucosidase deficiency, glocucerebrosidase deficiency, glucosylceramide beta-glucosidase deficiency, kerasin thesaurismosis, lipoid histiocytosis (kerasin type), lipoid histiocytosis, Glucocerebrosidase deficiency
human disease characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body
Key facts
- Other names
- Gaucher's disease
- Specialty
- Endocrinology , neurology
- Symptoms
- Hepatosplenomegaly , hypersplenism , pancytopenia , joint pain, neurological symptoms (usually mild), yellowish skin, and osteoporosis
- Complications
- Cirrhosis , splenic rupture , bleeding, and infections
- Usual onset
- Young adulthood (Type I), infancy (Type II)
- Duration
- Lifelong
- Types
- Type I, type II, type III
- Causes
- Glucocerebrosidase deficiency
- Risk factors
- Having parents with the disease or are carriers of the disease
- Diagnostic method
- Genetic testing
- Differential diagnosis
- SMPD1-associated Niemann–Pick disease , Fabry disease
- Prevention
- Gene editing
- Treatment
- Enzyme replacement therapy
- Medication
- Alglucerase , imiglucerase , velaglucerase , taliglucerase alfa , miglustat , and eliglustat
- Prognosis
- Slightly shortened life expectancy (type I), death in early childhood (type II)
- Frequency
- 1 in 100 people are carriers
via Wikipedia infobox
Research
7,338 papers- Gaucher's Disease.The New England journal of medicine · 2022
- Gaucher's disease: past, present and future.Bailliere's clinical haematology · 1997
- Gaucher's disease.The New England journal of medicine · 1987
- Gaucher's disease.Indian journal of pathology & bacteriology · 1968
- Gaucher's disease.The Journal of the Association of Physicians of India · 2009
via PubMed
Wikidata facts
- Subclass of
- disease
- Named after
- Philippe Gaucher
- Image
- Acid beta glucosidase.png
Show 8 more facts
- NCI Thesaurus ID
- C61268
- health specialty
- neurology
- drug or therapy used for treatment
- miglustat
- genetic association
- PSAP
- exact match
- www.orpha.net/ORDO/Orphanet_355
- prevalence
- 0.00001225
- on focus list of Wikimedia project
- WikiProject Medicine
- Commons category
- Gaucher's disease
Sources (9)
via Wikidata · CC0
~15 min read
Encyclopedic overview
Gaucher's disease or Gaucher disease (/ɡoʊˈʃeɪ/) (GD) is a genetic disorder in which glucocerebroside (a sphingolipid, also known as glucosylceramide) accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen, and is caused by a hereditary deficiency of the enzyme glucocerebrosidase (also known as glucosylceramidase), which acts on glucocerebroside. When the enzyme is defective, glucocerebroside accumulates, particularly in white blood cells and especially in macrophages (mononuclear leukocytes, which is often a target for intracellular parasites). Glucocerebroside can collect in the spleen, liver, kidneys, lungs, brain, and bone marrow.
Manifestations may include enlarged spleen and liver, liver malfunction, skeletal disorders or bone lesions that may be painful, severe neurological complications, swelling of lymph nodes and (occasionally) adjacent joints, distended abdomen, a brownish tint to the skin, anemia, low blood platelet count, and yellow fatty deposits on the white of the eye (sclera). Persons seriously affected may also be more susceptible to infection. Some forms of Gaucher's disease may be treated with enzyme replacement therapy.
Excerpted from Wikipedia’s “Gaucher's disease” article, available under the CC BY-SA 4.0 licence.